Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 08, 2010
Lead Product(s) : Amlexanox
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Advanced Clinical Research Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 10, 2010
Lead Product(s) : Amlexanox
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Advanced Clinical Research Services
Deal Size : Inapplicable
Deal Type : Inapplicable